Retatrutide 15mg Peptide

Retatrutide 15mg represents a high-purity research peptide in lyophilized form which can be used in the laboratory to conduct controlled experiments. Being a tri-receptor agonist, the Retatrutide compound is studied in terms of its activity on the GIP, GLP-1 and glucagon receptor pathways.

The 15mg vial represents an average amount for research settings where there is a need for greater amounts than in smaller vials.

• 15mg Retatrutide per vial
• 99%+ peptide purity
• Lyophilised research material
• Sealed laboratory vial
• Batch-specific quality documentation
• UK dispatch available

For laboratory research purposes only. Not for human or veterinary consumption.

Retatrutide 15mg – Triple Agonist Research Peptide

Retatrutide has received considerable attention owing to its unique receptor-binding characteristics. As compared to other drugs that are designed with a view to targeting a specific receptor, Retatrutide functions as an agonist on three metabolic receptors, namely glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon.

The 15mg formulation is an ideal medium-sized drug formulation for laboratories to conduct experiments in case a small bottle does not suffice and at the same time there is no need for a larger formulation.

Retatrutide 15mg Product Specifications

Product	Retatrutide
Quantity	15mg per vial
Purity	99%+
Form	Lyophilised powder
Receptor profile	GIP, GLP-1 and glucagon agonist
CAS Number	2381089-83-2
Molecular weight	Approximately 4,731 g/mol
Packaging	Sealed research vial
Application	Laboratory research only

Why Choose Retatrutide 15mg?

The 15mg format sits between lower-quantity and larger research vials, making it a flexible option for laboratories conducting ongoing experimental work.

It may be particularly useful when a study requires multiple analytical procedures or when researchers want sufficient material from the same batch for a series of related experiments.

Selecting an appropriate vial quantity can also help laboratories manage research materials more efficiently while reducing unnecessary handling of larger quantities.

Triple Receptor Activity

Retatrutide is commonly described in scientific literature as a triple agonist because its molecular design targets three receptor pathways.

GIP receptors form part of the incretin signalling system and are investigated extensively in metabolic research.

GLP-1 receptors are another important area of metabolic and endocrine research.

Glucagon receptors contribute an additional signalling pathway that differentiates Retatrutide’s research profile from compounds targeting GLP-1 alone or combined GLP-1/GIP pathways.

Studying these pathways simultaneously allows researchers to investigate the biological effects associated with multi-receptor signalling under controlled experimental conditions.

99%+ Purity Research Peptide

Purity is an important consideration when selecting peptides for laboratory investigation. This Retatrutide 15mg product is specified at 99%+ purity, providing researchers with clearly defined material for analytical and experimental applications.

Relevant analytical documentation should always be reviewed alongside the physical product. Where provided, the Certificate of Analysis (COA) contains information associated with the specific production batch.

Researchers should rely on batch-specific documentation rather than assuming that results obtained for one batch apply universally to every vial.

Lyophilised Retatrutide 15mg

Retatrutide 15mg is supplied as a lyophilised powder. Lyophilisation removes water from the peptide preparation under controlled conditions, producing a dry material suitable for laboratory storage and subsequent experimental preparation.

Researchers should follow the storage instructions stated on the product packaging and corresponding documentation. Exposure to excessive heat, moisture and direct light should be avoided.

Once prepared for an experiment, handling and storage requirements may differ from those applicable to the original lyophilised material.

Quality & Batch Documentation

Research reproducibility depends partly on knowing exactly which material has been used during an experiment. For this reason, batch identification and analytical documentation are important elements of peptide research.

Where available, documentation accompanying Retatrutide 15mg can provide researchers with information concerning product identity, purity and the analytical methods applied to the relevant batch.

Laboratories should maintain appropriate records of batch numbers and associated documentation as part of their normal research procedures.

Retatrutide 15mg FAQs

What is Retatrutide 15mg?

Retatrutide 15mg is a research peptide containing 15mg of Retatrutide in a sealed laboratory vial. It is supplied as a lyophilised powder and is intended exclusively for controlled research applications.

What makes Retatrutide a triple agonist?

Retatrutide is described as a triple receptor agonist because it demonstrates activity at the GIP, GLP-1 and glucagon receptors. This multi-receptor profile is one of the main reasons the compound is being investigated scientifically.

What is the purity of Retatrutide 15mg?

This product is specified at 99%+ purity. Researchers should also consult the relevant batch documentation or Certificate of Analysis for analytical information associated with the supplied material.

Is 15mg different from a 5mg Retatrutide vial?

The primary difference is the quantity of Retatrutide supplied in each vial. A 15mg vial contains three times the total peptide material of a 5mg vial. The appropriate quantity depends on the requirements of the laboratory research programme.

How should Retatrutide 15mg be stored?

The unopened lyophilised material should be stored according to the conditions specified on its label and accompanying documentation. Researchers should protect laboratory peptides from inappropriate exposure to heat, moisture and direct light.

Is Retatrutide an approved medicine in the UK?

Retatrutide remains an investigational compound and should not be represented as an authorised UK medicine. Research-grade Retatrutide products are intended for laboratory investigation rather than therapeutic use.

Disclaimer: Retatrutide 15mg is supplied strictly for laboratory research purposes. It is not intended for human or veterinary consumption and must not be used to diagnose, treat, cure or prevent any medical condition.